脊髓cMyc-EZH2通路介导Sirt3下调在HIV相关神经病理性疼痛中的作用
该研究在大鼠模型中通过鞘内注射重组gp120与吗啡诱导HIV相关神经病理性疼痛,发现脊髓cMyc和EZH2表达上调、Sirt3表达下调;鞘内给予cMyc反义寡核苷酸、EZH2抑制剂GSK126或重组Sirt3均可减轻机械性痛觉超敏和热痛觉过敏,揭示cMyc-EZH2/H3K27me3表观遗传调控Sirt3的机制。
要点
- gp120M诱导的神经病理性疼痛大鼠脊髓中cMyc和EZH2表达上调,Sirt3表达下调。
- 鞘内抑制cMyc或EZH2,或补充重组Sirt3,可减轻gp120M大鼠的痛觉超敏。
- cMyc通过上调EZH2及H3K27me3富集表观遗传沉默Sirt3,参与HIV相关神经病理性疼痛。
核心结论
- 脊髓Sirt3下调由cMyc-EZH2/H3K27me3表观遗传机制介导,参与gp120M诱导的神经病理性疼痛。
研究设计与样本
- 大鼠模型研究,鞘内注射重组gp120与吗啡诱导神经病理性疼痛,采用von Frey纤维测机械缩足阈值、热板试验测热潜伏期,Western blot测脊髓cMyc、EZH2、Sirt3表达,并测试鞘内给予cMyc反义寡核苷酸、EZH2选择性抑制剂或重组Sirt3的镇痛效果。
主要发现
- 与对照相比,gp120M组脊髓背角cMyc表达上调(比值1.68 ± 0.08 vs 1.00 ± 0.14,P = .0132)。
- 与对照相比,gp120M组脊髓背角EZH2表达上调(比值1.76 ± 0.05 vs 1.00 ± 0.16,P = .006)。
- 与对照相比,gp120M组脊髓背角Sirt3表达下调(对照与gp120M比值1.00 ± 0.13 vs 0.43 ± 0.10,P = .0069)。
- 鞘内给予cMyc反义寡核苷酸、GSK126(EZH2选择性抑制剂)或重组Sirt3均减轻gp120M大鼠的机械性痛觉超敏和热痛觉过敏。
- ChIP显示gp120M大鼠脊髓背角cMyc与ezh2基因启动子结合富集增加,H3K27me3与sirt3基因启动子结合富集上调;荧光素酶报告基因证实cMyc介导ezh2转录、H3K27me3沉默sirt3转录。
关键数值与推荐
- 鞘内cMyc反义寡核苷酸可逆转gp120M诱导的cMyc与ezh2启动子结合富集增加。
- 鞘内GSK126可逆转gp120M诱导的sirt3启动子区H3K27me3富集增加。
- cMyc敲低可降低gp120M大鼠脊髓EZH2表达。
临床怎么用
- 提示靶向脊髓cMyc-EZH2/H3K27me3-Sirt3通路可能为HIV感染合并慢性阿片类药物使用患者的神经病理性疼痛提供新干预方向。
局限性
- 研究为大鼠临床前模型,结果尚未在人体验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical data demonstrate that chronic use of opioid analgesics increases neuropathic pain in people living with human immunodeficiency virus (HIV). Therefore, it is important to elucidate the molecular mechanisms of HIV-related chronic pain. In this study, we investigated the role of the transcription factor cMyc, epigenetic writer enhancer of zeste homology 2 (EZH2), and sirtuin 3 (Sirt3) pathway in HIV glycoprotein gp120 with morphine (gp120M)-induced neuropathic pain in rats. METHODS: Neuropathic pain was induced by intrathecal administration of recombinant gp120 with morphine. Mechanical withdrawal threshold was measured using von Frey filaments, and thermal latency using the hotplate test. Spinal expression of cMyc, EZH2, and Sirt3 were measured using Western blots. Antinociceptive effects of intrathecal administration of antisense oligodeoxynucleotide against cMyc, a selective inhibitor of EZH2, or recombinant Sirt3 were tested. RESULTS: In the spinal dorsal horn, gp120M upregulated expression of cMyc (ratio of gp120M versus control, 1.68 ± 0.08 vs 1.00 ± 0.14, P = .0132) and EZH2 (ratio of gp120M versus control, 1.76 ± 0.05 vs 1.00 ± 0.16, P = .006), and downregulated Sirt3 (ratio of control versus gp120M, 1.00 ± 0.13 vs 0.43 ± 0.10, P = .0069) compared to control. Treatment with intrathecal antisense oligodeoxynucleotide against cMyc, GSK126 (EZH2 selective inhibitor), or recombinant Sirt3 reduced mechanical allodynia and thermal hyperalgesia in this gp120M pain model. Knockdown of cMyc reduced spinal EZH2 expression in gp120M treated rats. Chromatin immunoprecipitation (ChIP) assay showed that enrichment of cMyc binding to the ezh2 gene promoter region was increased in the gp120M-treated rat spinal dorsal horn, and that intrathecal administration of antisense ODN against cMyc (AS-cMyc) reversed the increased enrichment of cMyc. Enrichment of trimethylation of histone 3 on lysine residue 27 (H3K27me3; an epigenetic mark associated with the downregulation of gene expression) binding to the sirt3 gene promoter region was upregulated in the gp120M-treated rat spinal dorsal horn; that intrathecal GSK126 reversed the increased enrichment of H3K27me3 in the sirt3 gene promoter. Luciferase reporter assay demonstrated that cMyc mediated ezh2 gene transcription at the ezh2 gene promoter region, and that H3K27me3 silenced sirt3 gene transcription at the gene promoter region. CONCLUSION: These results demonstrated that spinal Sirt3 decrease in gp120M-induced neuropathic pain was mediated by cMyc-EZH2/H3K27me3 activity in an epigenetic manner. This study provided new insight into the mechanisms of neuropathic pain in HIV patients with chronic opioids.
引用
- Zhu X, Yi H, Gu J, et al. Sirtuin 3 Mediated by Spinal cMyc-Enhancer of Zeste Homology 2 Pathway Plays an Important Role in Human Immunodeficiency Virus-Related Neuropathic Pain Model. Anesth Analg. 2024. PMID: 38446700. doi:10.1213/ANE.0000000000006873
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。